Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

AREDS2/Lutein/Zeaxanthin Supplement Supply

Open

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79727R0009.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--AREDS2 ophthalmic multivitamins

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedNov 10

subcontract

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets for prime contractors on Department of Veterans Affairs (VA) pharmaceutical supply projects. Manufactures or sources the AREDS2 formula, ensuring an uninterrupted supply for a base year and four option years. Requires a unique NDC number belonging to the offeror and strict adherence to labeling standards. Delivers the finished pharmaceutical product to Prime Vendor distribution points.

Similar Contracts

Same NAICS industry code

Antibodies Elution Kit Supplier (NSN 6550-01-346-4878)This subcontract involves the supply of finished Antibodies Elution Kits, identified by NSN 6550-01-346-4878, for prime contractors serving the Department of Defense Medical Supply Chain. The required kits must contain concentrated wash, eluting, and buffering solutions designed for the rapid acid elution of antibodies from red blood cells. All deliverables must strictly adhere to FDA regulations, MIL-STD-2073-1E packaging requirements, and Medical Marking Standard No. 1. The scope of work requires the delivery of two complete kits to Keesler AFB, with each kit maintaining a minimum shelf-life of one month. This procurement falls under NAICS code 325412 and is managed through the DLA Troop Support Medical Supply Chain.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 14 hours ago

DEADLINE

Gabapentin Capsules SupplyThis subcontract involves the supply of FDA-regulated Gabapentin Capsules (100 MG) to support prime contractors on Department of Defense medical supply chain projects. The scope of work requires the manufacture or procurement of ten bottles of capsules that strictly adhere to FDA regulations and USP Controlled Room Temperature standards of 25 degrees Celsius. To maintain a non-extendable shelf life of 36 months, all products must be handled in FDA-approved facilities and transported using climate-monitored shipping containers. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American Act. Performance will take place in Washington, DC, under NAICS code 325412. Interested parties must note the response deadline of November 16, 2026, to ensure all regulatory and delivery specifications are met for this pharmaceutical procurement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

Supplier of Hypoallergenic Soft Tissue Massage CreamThis subcontract involves the supply of non-greasy, hypoallergenic soft tissue massage cream for prime contractors supporting the Medical Supply Chain Pharm FSA under the Department of Defense. The supplier must provide products that strictly adhere to FDA regulations and meet the specifications of NSN 6508017007944. To ensure product integrity, items must be stored in heated environments maintained at 40 degrees Fahrenheit or above. The contract requires the delivery of six 15 oz containers to Fort Polk, Louisiana, on a FOB Destination basis. All packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. This procurement falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

Povidone-Iodine Cleansing Solution ManufacturerThis subcontract involves the manufacture and supply of Povidone-Iodine Cleansing Solution for prime contractors supporting MEDICAL SUPPLY CHAIN PHARM FSA projects under the Department of Defense. The solution must be produced according to USP standards, featuring a 7.5% active ingredient and a shelf life of 36 months. The product is to be delivered in one-gallon bottles, which must include SDS and Hazardous Communication Standard labels in accordance with 29 C.F.R. 1910.1200. Additionally, the manufacturer must ensure full compliance with the Buy American Act. Performance for this contract is designated for FPO 96665.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

Pan-Africa Polyvalent Antivenin SupplierThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Pan-Africa polyvalent equine F(ab)2 immunoglobulin fragments antivenin. The biological therapeutics are designed to treat snakebite envenomation from 25 different species and are intended for prime contractors fulfilling DLA supply contracts. The delivery requirement consists of 6 cases containing a total of 216 vials, shipped FOB Destination. To qualify, the supplier must possess pharmaceutical manufacturing facilities and maintain strict compliance with FDA regulatory approvals. Additionally, all deliverables must adhere to MIL-STD-2073-1E and RP001 DLA Packaging Requirements. The contract falls under NAICS code 325412, with a response deadline set for November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0271

This procurement involves the supply of Povidone-Iodine Cleansing Solution, USP, with a 7.5% active ingredient for external use. The product must be delivered in one-gallon bottles with a total shelf life of 36 months, ensuring at least 31 months remain upon delivery to the first government activity. Storage must be maintained at 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The contract specifies delivery to the USS Harpers Ferry and USS Carter Hall, with a required delivery timeline of 20 days and FOB Destination terms. The contractor must adhere to strict packaging and marking standards, utilizing Medical Marking Standard No. 1 and MIL-STD-129. Hazardous materials must be packaged according to TQ requirement IP025 and FED-STD-313, and suppliers are required to submit Safety Data Sheets and Hazardous Communication Standard labels per 29 C.F.R. 1910.1200 prior to award. The contract is governed by various FAR and DFARS clauses, including requirements for safeguarding covered defense information, compliance with the Buy American Act, and the prohibition of covered defense telecommunications equipment. All payment requests must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

VARICELLA VIRUS VACCIN

Solicitation # SPE2DP-27-T-0243

Solicitation SPE2DP-27-T-0243 is a small business set-aside request for quotation issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of one package of lyophilized Varicella Virus Vaccine Live (NSN 6505-01-413-1331). Each package must contain 10 single dose vials of live vaccine and 10 vials of diluent, totaling 20 vials. The product, manufactured by Merck Sharp & Dohme LLC, is FDA regulated and must be drop shipped directly from the manufacturer to the destination in Camp Zama, Japan, within 20 days after order. The vaccine is a Type I Code K item with a non-extendable shelf life of 18 months, with a requirement that no more than 15 months have elapsed from the date of manufacture to the date of delivery. Strict storage and handling protocols are required, including maintaining a frozen temperature between -50C and -15C. Packaging must be commercial and comply with MIL-STD-2073-1E and Special Packaging Instructions MPPWN00001, while labeling must adhere to Medical Marking Standard No. 1B. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

GABAPENTIN CAPSULES

Solicitation # SPE2DP-27-T-0270

Solicitation SPE2DP-27-T-0270 is a Small Business Set-Aside procurement issued by the Defense Logistics Agency for the acquisition of 10 bottles of Gabapentin Capsules, 100 MG, in quantities of 100 per bottle. This FDA-regulated drug must be stored at 25C with permitted excursions between 15C and 30C per USP Controlled Room Temperature standards. The item has a non-extendable shelf life of 36 months. Delivery is required FOB Destination to a medical detachment in Washington, DC, with a required delivery date of November 12, 2026. The contract mandates commercial packaging and packing, requiring each unit to be in a sealed container to prevent damage, with shipping containers ensuring safe delivery. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payment. The procurement incorporates various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 cybersecurity requirements, and strict prohibitions on covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 14 hours ago

DEADLINE

Pharmaceutical Labeling and Barcoding ServicesThis subcontract for Pharmaceutical Labeling and Barcoding Services involves the final packaging and preparation of Nitroglycerin patches for prime contractors serving the Department of Veterans Affairs and the Department of Defense. The scope of work includes boxing patches in 30-unit quantities, applying barcodes to both individual patches and outer boxes, and ensuring all unique NDC labels comply with FDA regulations. A critical requirement is that label adhesion must be managed to allow for subsequent VA over-labeling. The project is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, falling under NAICS code 325412. The objective is to deliver retail-ready, fully barcoded, and labeled boxes of patches that meet all federal and agency specifications.

Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

Nitroglycerin Transdermal Patch ManufacturingNac Pharmaceuticals is seeking a subcontractor to manufacture and supply Nitroglycerin transdermal patches in strengths of 0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg. These products are intended for prime contractors supporting Department of Veterans Affairs pharmaceutical supply contracts. The manufacturing process must utilize pharmaceutical grade Nitroglycerin API and adhere to FAR Part 12 commercial item standards. To be eligible, the provider must operate FDA-approved manufacturing facilities and ensure each product has a unique National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of November 18, 2026.

Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

6505--Nitroglycerin Patches

Solicitation # 36E79727R0010

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement for Nitroglycerin Patches under solicitation 36E79727R0010. This contract will serve the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The procurement covers four strengths of Nitroglycerin patches (0.1 mg, 0.2 mg, 0.4 mg, and 0.6 mg), with estimated annual usage ranging from 2,213 to 10,044 boxes. All patches must be supplied in boxes of 30 and must feature barcoding on both the individual patch and the outside box. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, without being affixed over another label. Additionally, the labels must allow VA labels to adhere securely over them. This solicitation will be issued in commercial item format per FAR Part 12, with a tentative issuance date of December 1, 2026, and a closing date of December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

6505--AREDS2 ophthalmic multivitamins

Solicitation # 36E79727R0009

The Department of Veterans Affairs National Acquisition Center is initiating an unrestricted procurement under solicitation 36E79727R0009 for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN capsules or tablets. This contract is designed to provide an uninterrupted source of supply for the Department of Veterans Affairs, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The estimated annual requirement is 829,230 bottles of 120-count packaging, with distribution managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The contract will be awarded to a single responsible offeror for a base period of one year, followed by four pre-priced one-year option periods. The procurement follows FAR Part 12 commercial item format under NAICS code 325412. Strict labeling requirements apply: the contractor must provide a unique NDC number, and their label must be the only one on the product, with a prohibition against affixing labels over existing ones. The solicitation is expected to be issued electronically via SAM.gov on approximately December 23, 2026, with a tentative closing date of January 13, 2027.

Nac Pharmaceuticals (36E797)

POSTED

about 19 hours ago

DEADLINE

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

Pharmaceutical Supply of 300 mcg and 480 mcg Non-Safety SyringesThis subcontract involves the manufacture and supply of pre-filled non-safety syringes containing 300 mcg and 480 mcg medication for prime contractors supporting Department of Veterans Affairs pharmaceutical supply projects. The scope of work includes producing pharmaceutical dosages with unique NDC numbers and providing commercial packaging in both individual units and boxes of ten. Distribution of these labeled syringes is managed through the VA/DoD Pharmaceutical Prime Vendor Programs. The opportunity is associated with NAICS code 325412 and is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, with a response deadline set for December 15, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 1 month

Filgrastim Biosimilar (VA-27-00012533)

Solicitation # 36E79727R0001

The Department of Veterans Affairs, through the National Acquisition Center, is soliciting a contract for Filgrastim Biosimilar under solicitation number 36E79727R0001. This procurement is issued in commercial item format in accordance with FAR Part 12 and is managed by point of contact Dov Vysnia. The contract structure consists of an initial one-year period followed by four pre-priced one-year option periods. Distribution of the pharmaceutical products will be handled through the respective Pharmaceutical Prime Vendor Programs of the VA and the Department of Defense. The scope of work requires the provision of non-safety syringes in 300 mcg and 480 mcg dosages, which must be specifically labeled for use by patients or caregivers. Offerors are required to provide a unique NDC number and the exact product name as it appears on the label. Strict labeling guidelines mandate that the contractor's label be the only one on the product, prohibiting the placement of labels over existing ones, though the packaging must allow VA labels to adhere securely on top. Required commercial packaging includes individual syringes and boxes of ten syringes. Proposals must be submitted electronically via SAM.gov by December 15, 2026, at 2:30 PM Central Time.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 1 month

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Prime Vendor Distribution ServicesThis subcontract for Pharmaceutical Prime Vendor Distribution Services involves the logistics and distribution of pharmaceuticals for prime contractors serving the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The scope of work requires the use of pharmaceutical-grade warehousing and logistics systems to integrate with VA and DOD Prime Vendor Programs, ensuring an uninterrupted supply chain and delivery to end-user agencies. Managed under NAICS code 424210 and associated with Nac Pharmaceuticals and the Department of Veterans Affairs, the opportunity was posted on October 29, 2026. Interested parties must submit their responses by the deadline of November 23, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Supply of Ramipril Capsules (Multiple Dosages)This subcontract through Nac Pharmaceuticals supports the Department of Veterans Affairs, DOD, BOP, and IHS by providing Ramipril capsules in 1.25mg, 2.5mg, and 5mg strengths. The agreement ensures an uninterrupted supply of these medications, requiring that all products be delivered in non-glass bottling and packaging and assigned a unique National Drug Code number. The contractor must adhere to FAR Part 12 regulations and deliver the specific quantities of capsules as outlined in the contract line item numbers. This procurement falls under NAICS code 325412, with a response deadline set for November 23, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Ramipril Capsules RFP

Solicitation # 36E79726R0034

The VA National Acquisition Center is issuing an unrestricted Request for Proposal, solicitation 36E79726R0034, for the procurement of Ramipril capsules to support the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract will be awarded to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DOD. The procurement is conducted in commercial item format according to FAR Part 12 under NAICS code 325412. The requirement covers various Ramipril capsule strengths and bottle sizes, including 1.25mg, 2.5mg, 5mg, and 10mg options in 100-count and 500-count bottles, with total estimated annual requirements ranging from 1,611 to 15,956 units per item. Critical compliance requirements include the provision of a unique NDC number and the exact label name for each drug. Additionally, the use of glass bottles is strictly prohibited. The solicitation is expected to be issued around November 16, 2026, with a tentative closing date of November 30, 2026. Amber Zavala serves as the primary point of contact for this procurement.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime VendorsThis subcontract, issued by Nac Pharmaceuticals for the Department of Veterans Affairs, involves the logistics and distribution of pharmaceuticals. The primary scope of work requires the delivery of pharmaceutical products to multiple Government Prime Vendor distribution centers under FOB Destination terms, with a strict requirement for proof of delivery. Classified under NAICS code 493110, the contract focuses on specialized transportation and supply chain management to ensure medical supplies reach their intended destinations. The opportunity was posted on February 4, 2026, and is managed through the Department of Veterans Affairs agency framework.

General Warehousing and Storage

POSTED

DEADLINE

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)This subcontract, issued by Nac Pharmaceuticals under the Department of Veterans Affairs, involves the procurement of USP-grade bulk Metoprolol Tartrate Active Pharmaceutical Ingredient (API) for formulation purposes. The supplier is required to provide a Certificate of Analysis (CoA) to ensure quality standards and must strictly adhere to Buy American requirements. The contract is categorized under NAICS code 325411 and was posted on February 4, 2026. It focuses on the secure supply of pharmaceutical ingredients necessary for the production of medication within the federal healthcare framework.

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS